Vincent Charles Marconi MD
Professor, Medicine, Emory University School of Medicine
Join to View Full Profile
1670 Clairmont RdDecatur, GA 30033
Phone+1 404-321-6111
Dr. Marconi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 2003 - 2005
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2000 - 2003
Johns Hopkins University School of MedicineClass of 2000
Certifications & Licensure
GA State Medical License 2009 - 2027
MA State Medical License 2002 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2017
Clinical Trials
- A Commitment Device for Medication Adherence Among HIV Patients Start of enrollment: 2011 Oct 01
- Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure Start of enrollment: 2014 Dec 01
- Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System Start of enrollment: 2018 Oct 15
Publications & Presentations
PubMed
- Brief Report: Dolutegravir-Based Therapy, Diet, Physical Activity, and Weight Gain: A 48-week Prospective Cohort in South Africa.Dessie Tien, Nomathemba Chandiwana, Gugulethu Shazi, Geoffrey Chen, Smart Mabweazara
Journal of Acquired Immune Deficiency Syndromes. 2026-04-01 - Epigenetic Age Acceleration and Frailty Among People with HIV.Krisann K Oursler, Yan V Sun, Alicia J Lozano, Ke Xu, Kaku A So-Armah
AIDS Research and Human Retroviruses. 2026-04-01 - Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study.Y Joseph Hwang, Catherine R Lesko, Todd T Brown, G Caleb Alexander, Keri N Althoff
The Lancet. HIV. 2026-03-27
Press Mentions
Third Transplant Patient Cured of HIV Marks Important FirstsFebruary 16th, 2022- Study Shows Benefit of Baricitinib for Ventilated COVID PatientsFebruary 14th, 2022
- Emory Launches Study to Understand Long COVID-19 as Part of a Nationwide InitiativeNovember 4th, 2021
Grant Support
- REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRDVANDERBILT UNIVERSITY MEDICAL CENTER2024–2028
- Phase II study to evaluate the efficacy and safety of baricitinib for reduction of HIV in the central nervous systemEMORY UNIVERSITY2022–2027
- Host Genetic and Epigenetic Factors of the Progression, Comorbidities and Outcomes of Viral InfectionVETERANS HEALTH ADMINISTRATION2022–2026
- Multi-omic Predictors of Renal Function among HIV-infected Individuals of African AncestryEMORY UNIVERSITY2020–2025
- Integrating HIV and hEART health in South Africa (iHeart-SA)WITS HEALTH CONSORTIUM (PTY), LTD2020–2025
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
